Clinical Trials

Parkinson Disease 4, Autosomal Dominant Lewy Body, Prostatic Neoplasms

NCT02376296 2022-02-17

Observational Study of Docetaxel Exposure in Metastatic Prostate Cancer Patients

Completed

35 enrolled

Prostatic Neoplasms

NCT00466440 2020-11-06

A Phase 2 Study With Enzastaurin Plus Chemotherapy or Placebo Plus Chemotherapy for Prostate Cancer Patients

108 enrolled 22 charts

Prostatic Neoplasms

NCT03419442 2020-10-22

Multi-academic Center Study of Xofigo Patients

Completed

150 enrolled

Prostatic Neoplasms

NCT01194960 2020-10-19

TroVax® In Subjects With Hormone Refractory Prostate Cancer (HRPC)

Phase 2 Terminated

25 enrolled

Prostatic Hyperplasia, Prostatic Neoplasms

NCT01084655 2019-07-30

Study of TAK-700 in Combination With Docetaxel and Prednisone in Men With Metastatic Castration-Resistant Prostate Cancer

Phase 1/2 Completed

38 enrolled 29 charts

Prostatic Neoplasms

NCT01308567 2019-06-05

FIRSTANA

1,168 enrolled 17 charts

Prostatic Neoplasms

NCT00642018 2019-04-03

A Study of an Experimental Chemotherapy Combination to Treat Hormone Refractory Prostate Cancer

154 enrolled 20 charts

Prostatic Neoplasms

NCT00988208 2018-04-04

Mainsail

1,059 enrolled 27 charts

Prostatic Neoplasms

NCT02105675 2017-05-24

Phase II Study of DCVAC/PCa Added to Standard Chemotherapy for Men With Metastatic Castration Resistant Prostate Cancer

60 enrolled

Neoplasm Metastasis, Prostatic Neoplasms

NCT00744497 2016-10-17

READY

1,930 enrolled 23 charts

Prostatic Neoplasms

NCT01188187 2016-10-14

SYNERGY

1,022 enrolled

Prostatic Neoplasms

NCT00498797 2016-10-07

E3-Hormone Refractory Prostrate Cancer Taxotere Combination

86 enrolled 8 charts

Neoplasm Metastasis, Prostatic Neoplasms

NCT00519285 2016-07-22

VENICE

1,224 enrolled 21 charts

Neoplasm Metastasis, Neoplasms, Prostatic Neoplasms

NCT00514267 2015-08-13

An Open-Label Study of YM155 + Docetaxel in Subjects With Advanced Hormone Refractory Prostate Cancer and Other Solid Tumors

Phase 1/2 Completed

32 enrolled

Neoplasms, Prostatic Neoplasms

NCT00327288 2015-06-24

Safety Study of Imexon Plus Docetaxel in Lung, Breast or Prostate Cancer Patients

BreastGenitourinaryThoracic

34 enrolled

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Prostatic Neoplasms

NCT00539968 2015-02-05

A Study to Evaluate the Safety, Tolerability, and Activity of Lonafarnib and Docetaxel (Study P04467AM1)(TERMINATED)

Phase 1/2 Terminated

5 enrolled

BreastGastrointestinalGenitourinaryGynecologicThoracic

Breast Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Stomach Neoplasms

NCT00511576 2015-01-08

Study to Evaluate Combination Treatment of MGCD0103 and Docetaxel (Taxotere®) for Subjects With Advanced Cancer Tumors

Phase 1 Terminated

54 enrolled

BreastGastrointestinalGenitourinaryThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Prostatic Neoplasms, Stomach Neoplasms

NCT00401765 2014-05-26

A Study of CNTO 328 in Patients With Metastatic Hormone-Refractory Prostate Cancer

40 enrolled

Prostatic Neoplasms

NCT00439270 2014-03-28

Study of Dasatinib and Docetaxel in Metastatic Hormone Refractory Prostate Cancer

Phase 1/2 Completed

49 enrolled 25 charts

Prostatic Neoplasms

NCT00808418 2014-02-03

A Study to Determine the Maximum Tolerated Dose of Elesclomol Sodium Given With a Fixed Dose of Docetaxel and Prednisone in Patients With Metastatic Prostate Cancer

34 enrolled

Neoplasm Metastasis, Neoplasms, Prostatic Neoplasms

NCT01576029 2013-12-24

SWITCH

2 enrolled

Prostatic Neoplasms

NCT00514917 2013-11-04

Rising PSA

Phase 3 Terminated

413 enrolled 21 charts

Prostatic Neoplasms

NCT00537381 2013-06-20

An Efficacy and Safety Study of Intetumumab (CNTO 95) in Participants With Metastatic Hormone Refractory Prostate Cancer

131 enrolled 15 charts

Prostatic Neoplasms

NCT00314782 2013-03-12

Phase I Study of ZD4054 (Zibotentan) and Docetaxel in Patients With Metastatic HRPC

44 enrolled

GenitourinaryOther solid neoplasmThoracic

Prostatic Neoplasms

NCT01604863 2012-11-01

A Study of HGS1036 in Combination With Chemotherapy in Subjects With Advanced Solid Malignancies

Phase 1 Suspended

54 enrolled

Lung Neoplasms, Mesothelioma, Neoplasms, Prostatic Neoplasms, Small Cell Lung Carcinoma

NCT00617669 2012-09-10

ENTHUSE M1C

1,494 enrolled 14 charts

Prostatic Neoplasms

NCT00436839 2012-07-09

Taxotere Prostate Cancer New Indication Registration Trial in China

228 enrolled

Prostatic Neoplasms

NCT00283062 2012-01-26

Adjuvant Leuprolide With or Without Docetaxel in High Risk Prostate Cancer After Radical Prostatectomy

228 enrolled 14 charts

Prostatic Neoplasms

NCT00031187 2011-10-24

Study of SGN-15, Antibody-Drug Conjugate, to Treat Hormone Refractory Prostate Cancer

160 enrolled

Neoplasms, Prostatic Neoplasms

NCT00050596 2011-06-27

Comparison Study of MDX-010 (CTLA-4) Alone and Combined With Docetaxel in the Treatment of Patients With Hormone Refractory Prostate Cancer

Prostatic Neoplasms

NCT00268593 2011-06-15

Pilot Efficacy Study of PI-88 With Docetaxel to Treat Prostate Cancer

48 enrolled

Prostatic Neoplasms

NCT00069888 2011-06-08

A Phase II Trial of Adjuvant Docetaxel in Patients At High Risk of Relapse Following Prostatectomy

83 enrolled

Prostatic Neoplasms

NCT00705822 2010-11-30

PROSTATA

Phase 3 Terminated

54 enrolled